These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5547395)

  • 1. [Potassium clearance in primary aldosteronism].
    Shioji R; Torigai T
    Saishin Igaku; 1971 Mar; 26(3):548-52. PubMed ID: 5547395
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 3. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 4. [Case of primary aldosteronism--considerations on the thiazide screening test].
    Hashimoto T; Sugita K; Narusawa T; Iino S; Niitani H
    Nihon Rinsho; 1968 Apr; 26(4):946-52. PubMed ID: 5693520
    [No Abstract]   [Full Text] [Related]  

  • 5. Infusion of chlorothiazide in a patient with primary aldosteronism. Observations on potassium clearance.
    Schacht RA; Frame B
    JAMA; 1967 Jul; 201(5):323-5. PubMed ID: 6071730
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of serum sodium to urinary sodium divided by (serum potassium)² to urinary potassium as a screening tool for primary aldosteronism.
    Steichen O; Blanchard A; Plouin PF
    Eur J Clin Invest; 2011 Feb; 41(2):189-94. PubMed ID: 20955208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 8. [Na+/K+--quotient in the urine].
    Truniger B
    Dtsch Med Wochenschr; 1975 Sep; 100(38):1918-9. PubMed ID: 1192961
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential response to thiazides and spironolactone in primary aldosteronism.
    Gwinup G; Steinberg T
    Arch Intern Med; 1967 Oct; 120(4):436-43. PubMed ID: 6058098
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modification of ionic balance by an injectable antialdosterone drug in resuscitation].
    Roquefeuil B; Nord D; Viguie E; Fischbach C
    Agressologie; 1972; 13(3):185-94. PubMed ID: 5086033
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary hyperaldosteronism--diagnostic approach and management.
    Seshadri MS; Kanagasabapathy AS; Cherian AM; Nair A; Jesudason SR
    J Assoc Physicians India; 1993 May; 41(5):266-8. PubMed ID: 8300455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of impaired urinary concentrating ability in normokalemic primary aldosteronism.
    Conte G; Dal Canton A; Balletta M; Meccariello S; Sabbatini M; Andreucci VE
    Clin Nephrol; 1984 Aug; 22(2):91-6. PubMed ID: 6383675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myopathy in association with primary hyperaldosteronism.
    Sambrook MA; Heron JR; Aber GM
    J Neurol Neurosurg Psychiatry; 1972 Apr; 35(2):202-7. PubMed ID: 5037033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
    Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
    J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of spironolactone on serum corticosteroids in primary hyperaldosteronism.
    Abshagen U; Spörl S; Oelkers W
    Klin Wochenschr; 1979 Feb; 57(4):173-80. PubMed ID: 423483
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydrochlorothiazide and its effect upon the urine content of sodium, potassium and chloride.
    ZATUCHNI J; KING W; RESINSKI M
    Am J Med Sci; 1959 Dec; 238():747-52. PubMed ID: 13847082
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of the QT interval in primary aldosteronism.
    Matsumura K; Fujii K; Kansui Y; Arima H; Iida M
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):66-9. PubMed ID: 15730437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the effect of the aldosterone-antagonist aldadeine-potassium on secondary aldosteronism after surgery with the heart-lung machine].
    Gleichmann U; Bircks W; Bostroem B; Kreuzer H
    Arzneimittelforschung; 1967 Jun; 17(6):741-4. PubMed ID: 5632376
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?
    Juutilainen AM; Voutilainen ET; Mykkänen L; Niskanen L
    Blood Press; 2005; 14(4):245-50. PubMed ID: 16126559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.